Piperine as a multi-target phytotherapeutic for osteoarthritis: mechanistic insights and emerging opportunities
Inflammopharmacology · 05.11.2026
DOI: 10.1007/s10787-026-02440-x ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Inflammopharmacology, online erschienen am 05.11.2026. Verfasst von Shriyeta Biswas und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmaceutical Science, Assam down town University, Panikhaiti, Guwahati, Assam, 781026, India. Die Arbeit nennt 78 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Piperine, the principal bioactive alkaloid of Piper nigrum and Piper longum, has emerged as a promising phytotherapeutic candidate for the management of osteoarthritis (OA), a prevalent degenerative joint disease and a leading cause of chronic pain, disability and reduced quality of life worldwide. Its therapeutic potential is attributed to a wide range of pharmacological activities, including anti-inflammatory, antioxidant, analgesic, immunomodulatory and chondroprotective effects. The increasing burden of OA, driven by population aging, obesity, and metabolic disorders, highlights the urgent need for safer and more effective therapeutic strategies, as current treatments mainly provide symptomatic relief and no disease-modifying osteoarthritis drugs have been approved for clinical use. PURPOSE: This review comprehensively discusses the pathophysiology of OA, the molecular mechanisms underlying the therapeutic effects of piperine, and emerging translational strategies aimed at improving its clinical translation for OA management and cartilage regeneration. METHODS: This narrative review examined experimental evidence on the pharmacological activities of piperine and evaluated recent advances in piperine-based delivery systems, including nanocarriers, polymeric matrices, biomimetic scaffolds, tissue-engineering constructs, and controlled-release formulations, with emphasis on their potential applications in OA management. RESULTS: Piperine may modulate OA-associated inflammatory and catabolic pathways, although its therapeutic efficacy and disease-modifying potential remain investigational. However, limited aqueous solubility, reduced systemic bioavailability, rapid metabolic clearance, and short systemic retention limit its clinical application. Advanced delivery systems may overcome these limitations by improving stability, enabling targeted delivery, enabling sustained release, and enhancing local therapeutic efficacy within the joint microenvironment. CONCLUSION: Piperine is a potential phytotherapeutic candidate for OA owing to its multifaceted pharmacological activities. Novel delivery strategies could address its pharmacokinetic limitations and accelerate its translation into clinically effective therapies for OA.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Pharmaceutical Science, Assam down town University, Panikhaiti, Guwahati, Assam, 781026, India.
- Faculty of Pharmaceutical Science, Assam down town University, Panikhaiti, Guwahati, Assam, 781026, India. dr.sensaikat@gmail.com.
Zitieren
APA
Biswas, S., Singh, N. A., & Sen, S. (2026). Piperine as a multi-target phytotherapeutic for osteoarthritis: mechanistic insights and emerging opportunities. Inflammopharmacology. https://doi.org/10.1007/s10787-026-02440-x
Vancouver
Biswas S, Singh NA, Sen S. Piperine as a multi-target phytotherapeutic for osteoarthritis: mechanistic insights and emerging opportunities. Inflammopharmacology. 2026. doi:10.1007/s10787-026-02440-x
BibTeX
@article{Biswas2026,
author = {Biswas, Shriyeta and Singh, N Anirudh and Sen, Saikat},
title = {Piperine as a multi-target phytotherapeutic for osteoarthritis: mechanistic insights and emerging opportunities},
journal = {Inflammopharmacology},
year = {2026},
doi = {10.1007/s10787-026-02440-x}
}
EUVIMED